Owen Witte awarded International Harrington Prize for Innovation in Medicine

Common antidepressants could help the immune system fight cancer, UCLA study finds

A widely used antidepressant drug could help the immune system fight cancer, according to a new research study from UCLA.

May 23, 2025

Vol.51 No.20

In Brief

Intermountain Health to expand stem cell collection for CAR-T cell therapy, bringing procedure to southern Utah

Intermountain Health is now offering a national expansion of CAR-T cell therapy, bringing cancer care closer to patients in southern Utah and Nevada.

May 16, 2025

Vol.51 No.19

Clinical Roundup

Shorter radiation therapy after prostate surgery safe, UCLA study finds

For men who undergo a radical prostatectomy for the treatment of prostate cancer, post-surgery radiation therapy can play a vital role in reducing the risk of recurrence.

May 16, 2025

Vol.51 No.19

Rewriting the rules of cancer treatment one nanobody at a time

I joined Translational Genomics Research Institute, part of City of Hope, late last year to launch the Center for Accelerated Nanotherapeutics.

USC team develops analytical tool to advance CAR T-cell therapy research

A team of researchers from the Keck School of Medicine of USC has developed an advanced tool for analyzing chimeric antigen receptor T cells, including how they evolve during manufacturing and which ones are most effective at killing cancer.

May 02, 2025

Vol.51 No.17

Clinical Roundup

UCLA test predicts which prostate cancer patients are most likely to develop long-term side effects from radiation therapy

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which patients with prostate cancer are at higher risk of developing long-lasting urinary side effects after receiving radiation therapy.

April 11, 2025

Vol.51 No.14

Owen Witte awarded International Harrington Prize for Innovation in Medicine

YOU MAY BE INTERESTED IN

Common antidepressants could help the immune system fight cancer, UCLA study finds

Intermountain Health to expand stem cell collection for CAR-T cell therapy, bringing procedure to southern Utah

Shorter radiation therapy after prostate surgery safe, UCLA study finds

Rewriting the rules of cancer treatment one nanobody at a time

USC team develops analytical tool to advance CAR T-cell therapy research

UCLA test predicts which prostate cancer patients are most likely to develop long-term side effects from radiation therapy

Renew today!

Subscriber content

Never miss an issue!

Login